Handelsavisen
prelaunch
WO
WOLF.V TSX Venture Miscellaneous Specialty Retailers

Grey Wolf Animal Health Corp

$1,77
Open in Charts → Attach watcher ⌖
CAD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
61,1M CAD
P/E
35,2x
EV / Rev
1,7x
Div yield
Op margin
4,8 %
ROE
0,5 %
Net margin
2,1 %
Debt / equity
0,38
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-08-09
Ex-dividend
TR 1Y
About

Grey Wolf Animal Health Corp operates in the retail sector, specializing in the sale of animal health products and services, primarily generating revenue through direct sales to consumers.

Business. Grey Wolf Animal Health Corp (WOLF.V) is a miscellaneous specialty retailer operating within the consumer cyclicals sector. The company generates revenue through the sale of products, with its primary listing on the TSX Venture exchange. Specific details regarding operating segments and geographic presence are not disclosed in the available data.

Classification92 %
SectorConsumer Cyclicals
Business sectorRetailers
IndustryMiscellaneous Specialty Retailers
ActivityRetailers
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
35,2x
P/E
Analysts
not yet wired
Ownership
JPMorgan Private Bank (United States)
largest disclosed fund holder
Profitability
0,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning WOLF.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary · THIS SECTOR+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to WOLF.V. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Grey Wolf Animal Health Corp (WOLF.V) is a miscellaneous specialty retailer operating within the consumer cyclicals sector. The company generates revenue through the sale of products, with its primary listing on the TSX Venture exchange. Specific details regarding operating segments and geographic presence are not disclosed in the available data.

    Classification92 %
    SectorConsumer Cyclicals
    Business sectorRetailers
    IndustryMiscellaneous Specialty Retailers
    ActivityRetailers
    AI synthesis
    GENERATED

    Grey Wolf Animal Health Corp maintains a capital structure with a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position compared to the industry median. The company's liquidity position is characterized by a current ratio of 3.17, suggesting strong short-term liquidity. However, the operating cash flow is negative at -1,812,690 CAD, which may raise concerns about the company's ability to sustain operations without external financing.

    In terms of profitability, the company's return on equity (ROE) is 0.5%, and return on assets (ROA) is 0.33%, both of which are below the industry median for profitability metrics. The net income of 126,070 CAD and operating income of 291,150 CAD indicate modest profitability, with a gross profit margin of 51.47% (3,112,160 CAD / 6,046,510 CAD revenue). These figures suggest that the company is not outperforming its peers in terms of generating returns on invested capital.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to higher risks if demand in its primary market fluctuates. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's exposure to different markets or product lines.

    The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The current fiscal year's revenue is 6,046,510 CAD, and there is no indication of a significant increase in the next fiscal year. The company's capital expenditure of -52,820 CAD suggests minimal investment in new projects or expansion, which may limit future growth opportunities.

    The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could necessitate additional financing. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares. The valuation adjustments applied in the custom valuations do not indicate significant overvaluation or undervaluation.

    There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests that the company may not be actively communicating with investors or disclosing material developments.

    Key takeaways
    • Grey Wolf Animal Health Corp has a conservative debt-to-equity ratio of 0.38, indicating a relatively low leverage position.
    • The company's ROE and ROA are below the industry median, suggesting that it is not generating strong returns on invested capital.
    • The company's revenue is concentrated in a single segment, with no geographic diversification disclosed, which may increase its exposure to market-specific risks.
    • The company's growth trajectory is uncertain, with no significant capital expenditure and no clear revenue growth projections.
    • The company faces a medium liquidity risk due to a negative operating cash flow and a low dilution risk as the number of shares outstanding remains unchanged.
    • **margin_outlook_rationale**: The company's gross profit margin is 51.47%, but the net income margin is only 2.09%, indicating that operating expenses are eroding profitability.
    • **rd_outlook_rationale**: There is no specific information provided about the company's research and development activities or their impact on future profitability.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Revenue grew 33.3% year-over-year to CAD 35.8 million, demonstrating strong top-line expansion momentum.

    Net income surged 135.1% to CAD 1.66 million, indicating significant improvement in overall profitability.

    Operating income increased 112.9% to CAD 4.06 million, reflecting substantial gains in core operational efficiency.

    Free cash flow rose 126.0% to CAD 3.84 million, highlighting robust cash generation capabilities.

    Operating margin of 4.8% exceeds the 3.9% median for Miscellaneous Specialty Retailers peers.

    BEAR CASE · 3

    High credit risk and a current ratio of 0.36 signal severe short-term liquidity constraints.

    Cash conversion ranks in the bottom quartile of the peer group, indicating inefficient cash management.

    Medium liquidity risk flags potential challenges in meeting immediate financial obligations despite recent growth.

    In focus — financials by report

    Valuation FY

    Market price
    $1,77
    Market cap
    $58.3M
    Enterprise value
    $62.3M
    P/E
    35.2x
    Non-GAAP P/E
    EV / Revenue
    1.7x
    EV / Op income
    15.4x
    EV / OCF
    P / B
    2.3x
    P / Tangible book
    2.3x
    Tangible book
    $25.2M
    Net cash
    -$4.0M
    Current ratio
    3.2
    Debt / equity
    0.4
    ROA
    0.3%
    ROE
    0.5%
    Cash conversion
    -1438.0%
    CapEx / revenue
    -0.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Corporate eventM&A horizon
    M&A probabilityconf 5 %
    Probability
    5 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-23 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-07-27

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin4,8 %Above median
    Net Margin2,1 %Below median
    ROE0,5 %Below median
    Capex / Rev-0,9 %Above P75
    D/E0,38Above median
    Cash Conv-14,38Bottom quartile

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    5 %
    Base rate
    3 %
    Band
    Moderate
    180-day horizon · target 2027-01-23 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 883 924 sh1 transactions1 insiders
    • CITIGROUP INC10% owner · Equity Swap (obligation to sell) → Common Stock, $0.00125 par valueAcquired 883 924 @ $26,12other · 2025-10-30

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Grey Wolf Animal Health Corp Market data — financials · 2026-05-30

    Ownership & reference

    Top holders

    • JPMorgan Private Bank (United States)Investment Managers · as of 2026-03-310,37 %$6M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,01 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$70M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,00 %$22M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$22M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$14M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$8M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$26M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$2M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$3M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$15M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$3M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$5M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$8M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$6M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net buying3 buys · 1 sellsnet $71K11 insiders · last 365d
    • Emerson David ToddChief Operating Officer · COMMON STOCKOther 3 299 @ $35,10$116K · 2026-07-15
    • Feurle Robert A.Director, CEO and Director · COMMON STOCKOther 8 247 @ $35,10$289K · 2026-07-15
    • KOHN BRADLEY DEVP Chief Legal/Global Affairs · COMMON STOCKOther 38 775 · 2026-07-01
    • Feurle Robert A.Director, CEO and Director · COMMON STOCKOther 29 307 @ $36,76$1,1M · 2026-05-01
    • ABATE ANTHONYDirector · COMMON STOCKOther 31 732 · 2025-12-17
    • Bokan Michael WDirector · COMMON STOCKOther 31 732 · 2025-12-17
    • HOU HONG QDirector · COMMON STOCKOther 31 732 · 2025-12-17
    • Jensen Mark EdwinDirector · COMMON STOCKOther 31 732 · 2025-12-17
    • Musser Eric SDirector · COMMON STOCKOther 31 732 · 2025-12-17
    • Walsh Paul V JrDirector · COMMON STOCKOther 31 732 · 2025-12-17
    • van Issum GregorCFO & Executive Vice President · COMMON STOCKOther 172 263 · 2025-12-08
    • Emerson David ToddChief Operating Officer · COMMON STOCKOther 126 931 · 2025-12-08
    • Feurle Robert A.Director, CEO and Director · COMMON STOCKOther 317 327 · 2025-12-08
    • CITIGROUP INC10% owner · Common Stock, $0.00125 par valueSold 194 423 @ $26,18$5,1M · 2025-10-31
    • CITIGROUP INC10% owner · Common Stock, $0.00125 par valueBought 24 773 @ $26,67$661K · 2025-10-31
    • CITIGROUP INC10% owner · Common Stock, $0.00125 par valueBought 53 530 @ $27,46$1,5M · 2025-10-31
    • CITIGROUP INC10% owner · Common Stock, $0.00125 par valueBought 116 002 @ $26,12$3,0M · 2025-10-30
    • Emerson David ToddChief Operating Officer · COMMON STOCKOther 21 300 · 2025-09-29
    • Emerson David ToddChief Operating Officer · COMMON STOCKOther 178 · 2025-09-29

    Short positioning

    24.5Mshares short+0.3% vs prior
    6.79days to cover
    41.2%short of daily vol
    1.8Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    WOLF.VCanonical
    TSX Venture · CAD

    Intel & risk

    PredictorM&A prob5 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Shareholders' equity (YoY) (2025-12-28 vs 2024-12-29): 68.4%Derived (calculated)
    • Total assets (YoY) (2025-12-28 vs 2024-12-29): -55.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-28 vs 2024-12-29): 67.6%Derived (calculated)
    • Current ratio (FY 2025-12-28): 6.50xDerived (calculated)
    • Debt-to-equity (FY 2025-12-28): 4.49xDerived (calculated)
    • Long-term debt (YoY) (2025-12-28 vs 2024-12-29): -69.4%Derived (calculated)
    • Shares outstanding (annual): 27.36MSEC XBRL filing
    • Total assets (annual): USD 3.45BSEC XBRL filing
    • Current assets (annual): USD 1.93BSEC XBRL filing
    • Total liabilities (annual): USD 2.82BSEC XBRL filing
    • Current liabilities (annual): USD 297.1MSEC XBRL filing
    • Shareholders' equity (annual): USD 627.4MSEC XBRL filing
    • Cash & equivalents (annual): USD 1.03BSEC XBRL filing
    • Long-term debt (annual): USD 1.96BSEC XBRL filing
    • EPS (basic) (YoY) (2025-06-29 vs 2023-06-25): -329.8%Derived (calculated)
    • Net margin (FY 2025-06-29): -212.4%Derived (calculated)
    • Gross margin (FY 2025-06-29): -16.1%Derived (calculated)
    • Capex (YoY) (2025-06-29 vs 2023-06-25): 33.9%Derived (calculated)
    • Cost of revenue (YoY) (2025-06-29 vs 2023-06-25): 70.5%Derived (calculated)
    • EPS (diluted) (YoY) (2025-06-29 vs 2023-06-25): -329.8%Derived (calculated)
    • Gross profit (YoY) (2025-06-29 vs 2023-06-25): -150.1%Derived (calculated)
    • Net income (YoY) (2025-06-29 vs 2023-06-25): -387.8%Derived (calculated)
    • Operating cash flow (YoY) (2025-06-29 vs 2023-06-25): -399.1%Derived (calculated)
    • Operating income (YoY) (2025-06-29 vs 2023-06-25): -326.3%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-08-04 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-15INSIDEREmerson David Todd transacted 3.3k sh — Chief Operating Officer ~$116k
    2026-07-15INSIDERFeurle Robert A. transacted 8.2k sh — Director, CEO and Director ~$289k
    2026-07-01INSIDERKOHN BRADLEY D transacted 38.8k sh — EVP Chief Legal/Global Affairs
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDER5 institutional position changes flagged
    2026-06-18FILING424B3 filing →
    2026-06-09FILINGS-1 filing →
    2026-06-09FILING424B3 filing →
    2026-06-09FILING424B3 filing →
    2026-06-09FILING8-K filing →
    2026-05-07FILING424B3 filing →
    2026-05-07FILING424B3 filing →
    2026-05-07FILING10-Q filing →
    2026-05-05FILING8-K filing →
    2026-05-01 00:00 UTCINSIDER1 insider transaction — 2026-05 · net sell $1.1M
    2026-05-01INSIDERFeurle Robert A. transacted 29.3k sh — Director, CEO and Director ~$1.08M
    2026-03-26FILING424B3 filing →
    2026-03-26FILING424B3 filing →
    2026-03-26FILING8-K filing →
    2025-12-17 00:00 UTCINSIDER9 insider transactions — 2025-12
    2025-12-17INSIDERABATE ANTHONY transacted 31.7k sh — Director
    2025-12-17INSIDERBokan Michael W transacted 31.7k sh — Director
    2025-12-17INSIDERHOU HONG Q transacted 31.7k sh — Director
    2025-12-17INSIDERJensen Mark Edwin transacted 31.7k sh — Director
    2025-12-17INSIDERMusser Eric S transacted 31.7k sh — Director
    2025-12-17INSIDERWalsh Paul V Jr transacted 31.7k sh — Director
    2025-12-08INSIDERvan Issum Gregor transacted 172.3k sh — CFO & Executive Vice President
    2025-12-08INSIDEREmerson David Todd transacted 126.9k sh — Chief Operating Officer
    2025-12-08INSIDERFeurle Robert A. transacted 317.3k sh — Director, CEO and Director
    2025-10-31 00:00 UTCINSIDER5 insider transactions — 2025-10 · $10.3M gross 1 derivative
    2025-10-31INSIDERCITIGROUP INC sold 194.4k sh Common Stock, $0.00125 par value — 10% owner ~$5.09M
    2025-10-31INSIDERCITIGROUP INC bought 24.8k sh Common Stock, $0.00125 par value — 10% owner ~$661k
    2025-10-31INSIDERCITIGROUP INC bought 53.5k sh Common Stock, $0.00125 par value — 10% owner ~$1.47M
    Showing the 40 most recent of 46 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage